Hoover Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hoover Financial Advisors's PFE Position: Q2 2021 in Review
Hoover Financial Advisors increased its Pfizer (PFE) stake by 19% in Q2 2021, buying an estimated $105K and bringing the position to 17,021 shares worth $667K. The position accounts for 0.12% of the portfolio, ranked #67.
Hoover Financial Advisors first reported a position in PFE in Q4 2018 and has held it in 11 quarters since. The position peaked at $713K in Q2 2019. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Hoover Financial Advisors held 17,021 shares of Pfizer worth $667K as of Q2 2021.
- Hoover Financial Advisors bought 2,688 Pfizer shares in Q2 2021, an estimated $105K.
- Pfizer made up 0.12% of Hoover Financial Advisors's portfolio in Q2 2021, its #67 holding.
- Hoover Financial Advisors first reported a position in Pfizer in Q4 2018 and has held it in 11 quarters since.
- Hoover Financial Advisors's Pfizer position peaked at $713K in Q2 2019.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.